IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.450
NA - Nord America 2.222
AS - Asia 1.733
SA - Sud America 577
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 8.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.162
RU - Federazione Russa 2.096
SG - Singapore 815
IE - Irlanda 496
BR - Brasile 492
SE - Svezia 295
HK - Hong Kong 294
CN - Cina 292
IT - Italia 163
FR - Francia 125
IN - India 87
DE - Germania 80
VN - Vietnam 60
NL - Olanda 38
AR - Argentina 35
GB - Regno Unito 33
CA - Canada 30
BD - Bangladesh 28
FI - Finlandia 26
ZA - Sudafrica 23
AT - Austria 21
JP - Giappone 20
PL - Polonia 20
TR - Turchia 16
PK - Pakistan 15
EC - Ecuador 14
IQ - Iraq 12
MX - Messico 12
UA - Ucraina 11
ES - Italia 10
ID - Indonesia 10
CO - Colombia 9
EU - Europa 9
MA - Marocco 9
MY - Malesia 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AU - Australia 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
LT - Lituania 6
PH - Filippine 6
UZ - Uzbekistan 6
CL - Cile 5
KE - Kenya 5
JO - Giordania 4
KR - Corea 4
PE - Perù 4
TW - Taiwan 4
BE - Belgio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
IL - Israele 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
NP - Nepal 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
CR - Costa Rica 1
FJ - Figi 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.058
Salva come PNG Salva come JPEG
Città #
Moscow 587
Dublin 496
Ashburn 470
Singapore 443
Hong Kong 293
Nyköping 277
Dallas 257
San Jose 159
The Dalles 127
Lauterbourg 88
Chandler 86
Princeton 86
Medford 85
Los Angeles 84
Des Moines 66
Messina 59
Pune 48
Council Bluffs 45
Beijing 39
Redondo Beach 39
Buffalo 37
São Paulo 36
Tianjin 36
Munich 29
Brooklyn 28
Ho Chi Minh City 26
New York 25
Rio de Janeiro 25
Orem 24
Boardman 20
Guangzhou 20
Nuremberg 19
Tokyo 19
Santa Clara 15
Warsaw 15
Amsterdam 14
Montreal 14
Wilmington 14
Frankfurt am Main 13
Johannesburg 13
San Francisco 12
Turku 12
Vienna 12
Chennai 11
Hanoi 11
Atlanta 10
Phoenix 10
Shenzhen 10
Dhaka 9
Porto Alegre 9
Rome 9
Stockholm 9
Belo Horizonte 8
Catania 8
Denver 8
Düsseldorf 8
Guarulhos 8
Jiaxing 8
Shanghai 8
Brno 7
Campinas 7
Chicago 7
Jinan 7
Palermo 7
Toronto 7
Boston 6
Charlotte 6
Goiânia 6
Hyderabad 6
Lappeenranta 6
London 6
Ningbo 6
Baghdad 5
Helsinki 5
Manchester 5
Mumbai 5
Norwalk 5
Poplar 5
Recife 5
Salvador 5
São Bernardo do Campo 5
Tashkent 5
Amman 4
Ankara 4
Araras 4
Augusta 4
Belford Roxo 4
Bexley 4
Cape Town 4
Casablanca 4
Curitiba 4
Istanbul 4
Joinville 4
Lahore 4
Manaus 4
Mexico City 4
Miami 4
New Delhi 4
Nova Iguaçu 4
Piracicaba 4
Totale 4.662
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 328
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 196
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 166
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 133
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 129
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 124
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 121
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 121
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 120
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 119
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 116
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 116
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 115
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 114
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 111
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 111
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 111
Alzheimer's disease: Abeta, tau and synaptic dysfunction 106
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 104
Autophagic/lysosomal dysfunction in Alzheimer's disease 103
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 100
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 100
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 98
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 98
A dynamic relationship between intracellular and extracellular pools of Abeta 96
Generation of a Biotin-Tagged Dual-Display Phage 95
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 91
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 90
The ubiquitin-proteasome system in Alzheimer‘s disease 85
Necroptosis activation in Alzheimer's disease 84
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 84
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 82
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 79
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 75
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 74
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 72
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 72
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 72
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 72
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 71
Intracellular amyloid-beta in Alzheimer‘s disease 70
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 69
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 69
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 69
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 69
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 69
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 69
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 69
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 68
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 68
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 68
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 68
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 67
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 66
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 66
Dyrk1 inhibition improves Alzheimer's disease-like pathology 66
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 65
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 65
Validation of a 2-day water maze protocol in mice 65
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 65
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 64
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 64
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 64
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 63
Congo red and thioflavin-T analogs detect Abeta oligomers 62
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 62
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 61
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 61
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 61
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 61
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 60
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 60
Engineered phage-silver nanoparticle complexes as a new tool for targeted therapies 59
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 59
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 59
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 58
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 58
The role of mTOR signaling in Alzheimer disease 57
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 56
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 56
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 56
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 56
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 56
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 55
Toxic role of K+ channel oxidation in mammalian brain 55
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 55
Neural stem cells improve memory in an inducible mouse model of neuronal loss 55
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 54
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 54
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 54
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 54
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 54
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 53
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 53
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 53
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 52
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 51
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 51
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 51
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 51
Totale 7.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 92 0
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20264.673 251 271 287 291 385 1.126 716 571 548 227 0 0
Totale 8.195